Skip to main content
Article thumbnail
Location of Repository

Beneficial effect of tibolone on mood, cognition, well-being, and sexuality in menopausal women

By Andrea Riccardo Genazzani, Nicola Pluchino, Francesca Bernardi, Manolo Centofanti and Michele Luisi


Tibolone is a synthetic molecule used extensively for the management of menopausal symptoms, with the proposed additional advantage of enhanced mood and libido. Tibolone, after oral administration, is rapidly converted into 3 major metabolites: 3α-hydroxytibolone and 3β-hydroxytibolone, which have estrogenic effects, and the Δ4-isomer, which has progestogenic and androgenic effects. The tissue-selective effects of tibolone are the result of metabolism, of enzyme regulation, and of receptor activation which vary in different tissues. Tibolone seems to be effective on estrogen-withdrawal symptoms such as hot flushes, sweating, insomnia, headache, and vaginal dryness, with results generally comparable to the effects exerted by estrogen-based treatments, and the additional property of a progestogenic activity on the endometrium. As well as relieving vasomotor symptoms, tibolone has positive effects on sexual well-being and mood, and improves dyspareunia and libido. These effects may depend on both estrogenic and androgenic actions exerted at the genital level and in the central nervous system, and on a reduction of sex-hormone-binding globulin and an increase of free testosterone, without affecting Δ-5 androgens levels. Based on the evidence available, tibolone is a valuable treatment option to relieve menopausal complaints, especially in women suffering persistent fatigue, blunted motivation, and loss of sexual desire despite an adequate estrogen replacement

Topics: Expert Opinion
Publisher: Dove Medical Press
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (1996). Androgen and postmenopausal women.
  2. (1999). Androgen replacement therapy: a commentary.
  3. (1985). Beta-endorphin in the male rat pituitarytestosterone infl uences the effects of cocaine.
  4. (2002). Cognitive effects of 10 years of hormonereplacement therapy with tibolone.
  5. (2000). Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women.
  6. (2001). Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. Fertil Steril,
  7. (2006). Effect of tibolone administration on central and peripheral levels of allopregnanolone and β-endorphin in female rats.
  8. (1984). Elevated levels of plasma beta-endorphin in a group of women with polycystic ovarian disease. Fertil Steril,
  9. (2005). Endocrinology of menopausal transition and its brain implications.
  10. (1995). Evidence for a role for the neurosteroid allopregnanolone in the modifi cations of reproductive function in female rats.
  11. (2003). Failure of tibolone to potentiate the pharmacological effect of fl uoxetine in postmenopausal major depression.
  12. (2004). HRT. In Climacteric and aging brain.
  13. (1985). Menopausal syndrome: plasma levels of – endorphin in postmenopausal women using a specifi c radioimmunoassay.
  14. (1991). Neurosteroids: a new function in the brain.
  15. (2001). Neurosteroids: beginning of the story. Int Rev Neurobiol,
  16. (1997). Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog Horm Res,
  17. (2003). Receptor profi ling and endocrine interactions of tibolone.
  18. (2001). Testosterone infl uences libido and well-being in women. Trends Endocrinol Metab,
  19. (2000). The effect of tibolone versus continuous combined norethisterone acetate and oestradiol on memory, libido and mood of postmenopausal women: a pilot study.
  20. (2002). The effects of tibolone on mood and libido.
  21. (2001). Tibolone: a compound with tissue specifi c inhibitory effects on sulfatase. Mol Cell Endocrinol,
  22. (1998). Tibolone: a review.
  23. (1988). Treatment of climacteric complaints with Org OD 14: a comparative study with oestradiol valerate and placebo.
  24. (2002). When to suspect androgen defi ciency other than at menopause. Fertil Steril,

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.